Literature DB >> 19239818

Genitourinary long-term outcomes for childhood cancer survivors.

Margarett Shnorhavorian1, Debra L Friedman, Martin A Koyle.   

Abstract

The treatment of pediatric malignancies represents one of the success stories of modern medicine. As survival has increased, the focus is now on minimizing harmful effects of treatment. There continue to be late toxicities and secondary malignancies of the genitourinary (GU) system for childhood cancer survivors related to the specific therapeutic exposures. A systematic approach is important for prevention and treatment of these adverse late GU effects.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19239818     DOI： 10.1007/s11934-009-0024-9

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN： 1527-2737            Impact factor:   3.092


  37 in total

1.  Hemolytic-uremic syndrome following bone marrow transplantation in adults for hematologic malignancies.

Authors:  S N Rabinowe; R J Soiffer; N J Tarbell; D Neuberg; A S Freedman; J Seifter; K W Blake; J G Gribben; K C Anderson; T Takvorian
Journal:  Blood       Date:  1991-04-15       Impact factor: 22.113

2.  Cyclophosphamide-induced hemorrhagic cystitis. A review of 100 patients.

Authors:  T J Stillwell; R C Benson
Journal:  Cancer       Date:  1988-02-01       Impact factor: 6.860

3.  Late onset of renal dysfunction in survivors of bone marrow transplantation.

Authors:  N J Tarbell; E C Guinan; C Niemeyer; P Mauch; S E Sallan; H J Weinstein
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-07       Impact factor: 7.038

4.  Unilateral nephrectomy and cisplatin as risk factors of ifosfamide-induced nephrotoxicity: analysis of 120 patients.

Authors:  R Rossi; A Gödde; A Kleinebrand; M Riepenhausen; J Boos; J Ritter; H Jürgens
Journal:  J Clin Oncol       Date:  1994-01       Impact factor: 44.544

5.  Cisplatin therapy in childhood: renal follow up 3 years or more after treatment. Swiss Pediatric Oncology Group.

Authors:  N X von der Weid; B M Erni; C Mamie; H P Wagner; M G Bianchetti
Journal:  Nephrol Dial Transplant       Date:  1999-06       Impact factor: 5.992

6.  Late renal dysfunction in adult survivors of bone marrow transplantation.

Authors:  C A Lawton; E P Cohen; S W Barber-Derus; K J Murray; R C Ash; J T Casper; J E Moulder
Journal:  Cancer       Date:  1991-06-01       Impact factor: 6.860

7.  Congestive heart failure after treatment for Wilms' tumor: a report from the National Wilms' Tumor Study group.

Authors:  D M Green; Y A Grigoriev; B Nan; J R Takashima; P A Norkool; G J D'Angio; N E Breslow
Journal:  J Clin Oncol       Date:  2001-04-01       Impact factor: 44.544

8.  Late effects on renal glomerular and tubular function in childhood cancer survivors.

Authors:  Edit Bárdi; Anna V Oláh; Katalin Bartyik; Emoke Endreffy; Csaba Jenei; János Kappelmayer; Csongor Kiss
Journal:  Pediatr Blood Cancer       Date:  2004-11       Impact factor: 3.167

Review 9.  Preservation of fertility in children treated for cancer.

Authors:  W H B Wallace; A B Thomson
Journal:  Arch Dis Child       Date:  2003-06       Impact factor: 3.791

10.  Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study.

Authors:  J P Neglia; D L Friedman; Y Yasui; A C Mertens; S Hammond; M Stovall; S S Donaldson; A T Meadows; L L Robison
Journal:  J Natl Cancer Inst       Date:  2001-04-18       Impact factor: 11.816
View more
  2 in total

Review 1.  Cancer survivorship practices, services, and delivery: a report from the Children's Oncology Group (COG) nursing discipline, adolescent/young adult, and late effects committees.

Authors:  Debra Eshelman-Kent; Karen E Kinahan; Wendy Hobbie; Wendy Landier; Steve Teal; Debra Friedman; Rajaram Nagarajan; David R Freyer
Journal:  J Cancer Surviv       Date:  2011-09-06       Impact factor: 4.442

2.  Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.

Authors:  Esmee Cm Kooijmans; Arend Bökenkamp; Nic S Tjahjadi; Jesse M Tettero; Eline van Dulmen-den Broeder; Helena Jh van der Pal; Margreet A Veening
Journal:  Cochrane Database Syst Rev       Date:  2019-03-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.